Insights On Trial Design

  1. Psychedelics As Therapeutics – What Developers Need To Know 10/29/2023

    Drug developers and others intrigued by the dynamic and promising field of psychedelics as therapeutics can gain valuable guidance from a recap of the 3rd annual Psychedelic Therapeutic and Drug Development Conference.

  2. Health Equity In Clinical Trials 10/31/2024

    Discover how authentic patient storytelling is advancing clinical trial diversity and trust—watch Merck & Co.’s award-winning video series produced by Jumo Health, featuring real voices from minority communities.

  3. Build Your Diversity Action Plan With AI And Patient Insights 5/29/2024

    Discover how AI and patient insights can help you build a compliant Diversity Action Plan and overcome barriers to achieve diverse clinical trial enrollment.

  4. How To Enroll 612 Patients In A Neurology Study On Time And Within Budget Despite Hurdles Caused By The Pandemic 7/23/2024

    Discover how a leading Indian pharmaceutical manufacturer and an Eastern European CRO successfully navigated the challenges of conducting clinical trials during the COVID-19 pandemic.

  5. Pros And Cons Of Basing Clinical Trials In Today's European Landscape 1/31/2024

    Explore the essential considerations for sponsors and CROs as they navigate the advantages and challenges of clinical trial locations, particularly in the United States and Europe.

  6. Understanding The FDA's Push For More Representation In Clinical Trials 1/28/2025

    Take action to improve diversity in clinical trials by addressing underrepresentation and ensuring equitable access to medical interventions, as emphasized by the FDA’s new 2025 guidance.

  7. Outlook Good For 7 Drugs Up For Q3 Review 8/15/2024

    A total of 24 drugs, devices, diagnostics, and deals are expected to progress in the third quarter of 2024, including approval applications for 17 drugs. The estimated overall likelihood of approval is 90% or higher for seven of those drugs, including revumenib for acute myelogenous leukemia and KarXT for schizophrenia.

  8. Unlock Clinical Trial Enrollment ROI 11/3/2023

    Consider this diverse range of real-world perspectives, complemented by data-driven insights, when looking to enhance the speed, accessibility, and efficiency of clinical trial processes.

  9. Unveiling The Potential Of Psychedelic Therapies 7/30/2024

    Leading experts highlight the transformative potential of the rapidly evolving field of psychedelic therapies and underscore the importance of rigorous clinical trials and regulatory compliance.

  10. An Adept Travel Solution For Clinical Trial Participants 9/29/2023

    Unearth how ConneX simplifies participant retention and engagement by aligning travel arrangements with study and participant needs, all while adhering to sponsor policies and requirements.